Class information for:
Level 1: SURVIVIN//YM155//SURVIVIN EXPRESSION

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3854 1894 39.3 92%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
441 3       TRAIL//SURVIVIN//APOPTOSIS 26474
306 2             TRAIL//SURVIVIN//APOPTOSIS 18497
3854 1                   SURVIVIN//YM155//SURVIVIN EXPRESSION 1894

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 SURVIVIN authKW 9293575 57% 53% 1084
2 YM155 authKW 895273 3% 91% 61
3 SURVIVIN EXPRESSION authKW 178563 1% 92% 12
4 BIRC5 authKW 159206 1% 45% 22
5 SURVIVIN DELTA EX3 authKW 128963 0% 100% 8
6 SURVIVING authKW 113609 1% 41% 17
7 SURVIVIN SPLICE VARIANTS authKW 96722 0% 100% 6
8 SEPANTRONIUM BROMIDE authKW 82903 0% 86% 6
9 SURVIVIN 2B authKW 82903 0% 86% 6
10 OTORHINOLARYNGOL MOL CELLULAR ONCOL address 72539 0% 75% 6

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 14201 45% 0% 852
2 Pathology 1143 8% 0% 143
3 Cell Biology 1035 14% 0% 259
4 Medicine, Research & Experimental 730 8% 0% 159
5 Biochemistry & Molecular Biology 295 15% 0% 280
6 Hematology 260 4% 0% 83
7 Gastroenterology & Hepatology 114 3% 0% 60
8 Genetics & Heredity 102 5% 0% 86
9 Medical Laboratory Technology 85 1% 0% 26
10 Pharmacology & Pharmacy 68 6% 0% 119

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OTORHINOLARYNGOL MOL CELLULAR ONCOL 72539 0% 75% 6
2 BOYER MOL MED 436B 48361 0% 100% 3
3 IMMUNOL INFLAMMAT MED 48361 0% 100% 3
4 DIAGNOVA 36269 0% 75% 3
5 ACDSF 32241 0% 100% 2
6 FDN DR HENRI DUBOIS FERRIERE DINU LIPATTI 32241 0% 100% 2
7 NANOMED IMMUNOL MOL BIOL 32241 0% 100% 2
8 PATHOL FDN 32241 0% 100% 2
9 VINCIENCE GLOBAL SKIN 32241 0% 100% 2
10 VA CARDIAC 29014 0% 60% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOLOGY REPORTS 2050 2% 0% 36
2 CANCER LETTERS 1865 2% 0% 38
3 APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY 1294 1% 1% 11
4 INTERNATIONAL JOURNAL OF ONCOLOGY 1280 1% 0% 28
5 CANCER BIOLOGY & THERAPY 1266 1% 1% 15
6 CANCER GENE THERAPY 1163 1% 1% 12
7 MOLECULAR CANCER THERAPEUTICS 1115 1% 0% 17
8 MEDICAL ONCOLOGY 938 1% 0% 14
9 ONCOGENE 917 2% 0% 33
10 CLINICAL CANCER RESEARCH 865 2% 0% 29

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 SURVIVIN 9293575 57% 53% 1084 Search SURVIVIN Search SURVIVIN
2 YM155 895273 3% 91% 61 Search YM155 Search YM155
3 SURVIVIN EXPRESSION 178563 1% 92% 12 Search SURVIVIN+EXPRESSION Search SURVIVIN+EXPRESSION
4 BIRC5 159206 1% 45% 22 Search BIRC5 Search BIRC5
5 SURVIVIN DELTA EX3 128963 0% 100% 8 Search SURVIVIN+DELTA+EX3 Search SURVIVIN+DELTA+EX3
6 SURVIVING 113609 1% 41% 17 Search SURVIVING Search SURVIVING
7 SURVIVIN SPLICE VARIANTS 96722 0% 100% 6 Search SURVIVIN+SPLICE+VARIANTS Search SURVIVIN+SPLICE+VARIANTS
8 SEPANTRONIUM BROMIDE 82903 0% 86% 6 Search SEPANTRONIUM+BROMIDE Search SEPANTRONIUM+BROMIDE
9 SURVIVIN 2B 82903 0% 86% 6 Search SURVIVIN+2B Search SURVIVIN+2B
10 IAP 66207 2% 11% 37 Search IAP Search IAP

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 FUKUDA, S , PELUS, LM , (2006) SURVIVIN, A CANCER TARGET WITH AN EMERGING ROLE IN NORMAL ADULT TISSUES.MOLECULAR CANCER THERAPEUTICS. VOL. 5. ISSUE 5. P. 1087-1098 120 88% 251
2 LLADSER, A , SANHUEZA, C , KIESSLING, R , QUEST, AFG , (2011) IS SURVIVIN THE POTENTIAL ACHILLES' HEEL OF CANCER?.ADVANCES IN CANCER RESEARCH, VOL 111. VOL. 111. ISSUE . P. 1-37 136 74% 27
3 RODEL, F , SPRENGER, T , KAINA, B , LIERSCH, T , RODEL, C , FULDA, S , HEHLGANS, S , (2012) SURVIVIN AS A PROGNOSTIC/PREDICTIVE MARKER AND MOLECULAR TARGET IN CANCER THERAPY.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 22. P. 3679-3688 107 77% 56
4 ALTIERI, DC , (2003) SURVIVIN, VERSATILE MODULATION OF CELL DIVISION AND APOPTOSIS IN CANCER.ONCOGENE. VOL. 22. ISSUE 53. P. 8581-8589 97 78% 579
5 KELLY, RJ , LOPEZ-CHAVEZ, A , CITRIN, D , JANIK, JE , MORRIS, JC , (2011) IMPACTING TUMOR CELL-FATE BY TARGETING THE INHIBITOR OF APOPTOSIS PROTEIN SURVIVIN.MOLECULAR CANCER. VOL. 10. ISSUE . P. - 97 82% 74
6 RYAN, BM , O'DONOVAN, N , DUFFY, MJ , (2009) SURVIVIN: A NEW TARGET FOR ANTI-CANCER THERAPY.CANCER TREATMENT REVIEWS. VOL. 35. ISSUE 7. P. 553-562 99 70% 221
7 PENNATI, M , FOLINI, M , ZAFFARONI, N , (2008) TARGETING SURVIVIN IN CANCER THERAPY.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 12. ISSUE 4. P. 463-476 101 83% 115
8 LI, FZ , (2003) SURVIVIN STUDY: WHAT IS THE NEXT WAVE?.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 197. ISSUE 1. P. 8-29 129 72% 221
9 MOBAHAT, M , NARENDRAN, A , RIABOWOL, K , (2014) SURVIVIN AS A PREFERENTIAL TARGET FOR CANCER THERAPY.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 15. ISSUE 2. P. 2494-2516 93 67% 46
10 ALTIERI, DC , (2003) VALIDATING SURVIVIN AS A CANCER THERAPEUTIC TARGET.NATURE REVIEWS CANCER. VOL. 3. ISSUE 1. P. 46-54 84 71% 803

Classes with closest relation at Level 1


Rank Class id link
1 6794 XIAP//LIVIN//SMAC
2 6479 AURORA KINASE//AURORA A//AURORA KINASE INHIBITOR
3 27621 NORDIHYDROGUAIARETIC ACID//NDGA//LARREA DIVARICATA CAV
4 28260 CASP8 652 6N DEL//CASPASE8//CASP8
5 33575 DEGUELIN//DERRIS ELLIPTICA//2 HYDROXY 5 AMINOROTENONONE
6 27700 JOINT SERV BIOMARKER EVALUAT ONCOL//KI67 SCORE//LOCDIR
7 19375 OBLIMERSEN//G3139//ANTISENSE BCL 2
8 25640 SELINEXOR//XPO1//CRM1 INHIBITOR
9 27470 ANTIPSORIATIC COMPOUND//BCL 2 GENE TARGETING//CELI DEATH
10 33764 FARNESYLTHIOSALICYLIC ACID//SALIRASIB//FTS

Go to start page